Clientfirst Wealth Management, LLC Ark Genomic Revolution ETF (De Transaction History

Clientfirst Wealth Management, LLC

  • $122 Million
  • Q3 2025

A detailed history of Clientfirst Wealth Management, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Clientfirst Wealth Management, LLC holds 15,050 shares of ARKG stock, worth $404,694. This represents 0.34% of its overall portfolio holdings.

Number of Shares
15,050
Previous 14,825 1.52%
Holding current value
$404,694
Previous $360,000 15.83%
% of portfolio
0.34%
Previous 0.37%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
BUY
$22.91 - $27.85 $5,154 - $6,266
225 Added 1.52%
15,050 $417,000
Q2 2025

Aug 14, 2025
SELL
$18.34 - $24.56 $102,612 - $137,413
-5,595 Reduced 27.4%
14,825 $360,000
Q1 2025

Apr 30, 2025
BUY
$20.76 - $29.81 $223,170 - $320,457
10,750 Added 111.17%
20,420 $423,000
Q4 2024

Jan 28, 2025
BUY
$22.66 - $27.11 $219,122 - $262,153
9,670 New
9,670 $227,000

Others Institutions Holding ARKG

# of Institutions
295
Shares Held
20.4M
Call Options Held
2.53M
Put Options Held
2.8M
View Full List

About ARK GENOMIC REVOLUTION ETF (DE

ARKG Quotes by TradingView
  • Ticker ARKG
  • Sector ETFs
  • Industry ETFs
More about ARKG
Track This Portfolio

Track Clientfirst Wealth Management, LLC Portfolio

Follow Clientfirst Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clientfirst Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clientfirst Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email